COLB vs MRK · P/E 12, rev $1.63B vs P/E 33, rev $16.61B
Columbia Banking System Inc (COLB) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Columbia Banking System Inc (COLB) is a banks - regional company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported COLB revenue for 2026-06-30 was $1.63B. Net income was $400.0M. Revenue was up 99.3% from 2026-03-31 to 2026-06-30. COLB currently screens at market cap $8.58B and trailing P/E 11.6.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
COLB currently screens at market cap $8.58B and trailing P/E 11.6. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the COLB and MRK stock pages for the full models.
Not investment advice.